Cargando…
Microglia in Alzheimer’s Disease: Activated, Dysfunctional or Degenerative
Microglial activation has been considered a crucial player in the pathological process of multiple human neurodegenerative diseases. In some of these pathologies, such as Amyotrophic Lateral Sclerosis or Multiple Sclerosis, the immune system and microglial cells (as part of the cerebral immunity) pl...
Autores principales: | Navarro, Victoria, Sanchez-Mejias, Elisabeth, Jimenez, Sebastian, Muñoz-Castro, Clara, Sanchez-Varo, Raquel, Davila, Jose C., Vizuete, Marisa, Gutierrez, Antonia, Vitorica, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5958192/ https://www.ncbi.nlm.nih.gov/pubmed/29867449 http://dx.doi.org/10.3389/fnagi.2018.00140 |
Ejemplares similares
-
Soluble phospho-tau from Alzheimer’s disease hippocampus drives microglial degeneration
por: Sanchez-Mejias, Elisabeth, et al.
Publicado: (2016) -
Should We Open Fire on Microglia? Depletion Models as Tools to Elucidate Microglial Role in Health and Alzheimer’s Disease
por: Romero-Molina, Carmen, et al.
Publicado: (2021) -
Enhancing microtubule stabilization rescues cognitive deficits and ameliorates pathological phenotype in an amyloidogenic Alzheimer’s disease model
por: Fernandez-Valenzuela, Juan Jose, et al.
Publicado: (2020) -
In vivo modification of Abeta plaque toxicity as a novel neuroprotective lithium-mediated therapy for Alzheimer’s disease pathology
por: Trujillo-Estrada, Laura, et al.
Publicado: (2013) -
Defective lysosomal proteolysis and axonal transport are early pathogenic events that worsen with age leading to increased APP metabolism and synaptic Abeta in transgenic APP/PS1 hippocampus
por: Torres, Manuel, et al.
Publicado: (2012)